- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Our Story
Reva, the company was formed in 2009. We believe in 'Caring for healthier lives', and work towards empowering communities worldwide for healthier living regardless of geography or circumstances.
At Reva, we hold requisite infrastructures with a balanced reach across Regulated, Emerging & Expansion markets. We are committed to ensure access to affordable and quality medicines with special focus on Emerging & Expansion Markets.
Our Vision
Currently, Reva is focusing its resources for providing sustainable solutions relating to; Women Health, Oncology, Diabetes and Mental Illness. Our portfolio includes generics, OTC and biosimilars across a wide range of therapeutic areas.
We are committed to create healthier communities worldwide through outreach and better access to treatment. Due to our scientific excellence and supply chain network, we are uniquely positioned to improve access of medicine for patients across Emerging and Regulated markets.